-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 GzMaBjhuAWoM+UYaFs3t5jq+5Pv9RYmUXkw1aPmh2Pn/etI88fjsJ5xYQZCFUUU3
 t5CBCDXgvqyj2U/hf+hW8Q==

<SEC-DOCUMENT>0001099910-02-000088.txt : 20020415
<SEC-HEADER>0001099910-02-000088.hdr.sgml : 20020415
ACCESSION NUMBER:		0001099910-02-000088
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20020301
FILED AS OF DATE:		20020322

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			OXIS INTERNATIONAL INC
		CENTRAL INDEX KEY:			0000109657
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				941620407
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-08092
		FILM NUMBER:		02582620

	BUSINESS ADDRESS:	
		STREET 1:		6040 N CUTTER CIRCLE STE 317
		CITY:			PORTLAND
		STATE:			OR
		ZIP:			97217
		BUSINESS PHONE:		5032833911

	MAIL ADDRESS:	
		STREET 1:		6040 N CUTTER CIRCLE STE 317
		CITY:			PORTLAND
		STATE:			OR
		ZIP:			97217

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DDI PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DIAGNOSTIC DATA INC /DE/
		DATE OF NAME CHANGE:	19850312
<REPORTING-OWNER>

COMPANY DATA:	
	COMPANY CONFORMED NAME:			HAUSMAN MARVIN S MD
	CENTRAL INDEX KEY:			0001067956
<RELATIONSHIP>DIRECTOR

FILING VALUES:
	FORM TYPE:		3

BUSINESS ADDRESS:	
	STREET 1:		825 THIRD AVE
	STREET 2:		40TH FL
	CITY:			NEW YORK
	STATE:			NY
	ZIP:			10022
	BUSINESS PHONE:		5094275132

MAIL ADDRESS:	
	STREET 1:		825 THIRD AVE
	STREET 2:		40TH FL
	CITY:			NEW YORK
	STATE:			NY
	ZIP:			10022
</REPORTING-OWNER>
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>oxisintinc-mshausman_form3.txt
<DESCRIPTION>INITIAL STATEMENT OF OWNERSHIP OF SECURITIES
<TEXT>
                     U.S. SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549

                                     FORM 3

            INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
       Section 17(a) of the Public Utility Holding Company Act of 1935 or
               Section 30(f) of the Investment Company Act of 1940

________________________________________________________________________________
1.   Name and Address of Reporting Person

   HAUSMAN                            MARVIN                  S.
- --------------------------------------------------------------------------------
   (Last)                            (First)              (Middle)

                                #1 ASH LAKE ROAD
- --------------------------------------------------------------------------------
                                    (Street)

STEVENSON,                              WA                  99648
- --------------------------------------------------------------------------------
   (City)                            (State)                (Zip)
________________________________________________________________________________
2.   Date of Event Requiring Statement (Month/Day/Year)

     MARCH 7, 2002
________________________________________________________________________________
3.   IRS or Social Security Number of Reporting Person (Voluntary)

________________________________________________________________________________
4.   Issuer Name and Ticker or Trading Symbol

     OXIS INTERNATIONAL, INC. (symbol-OXIS.OB)
________________________________________________________________________________
5.   Relationship of Reporting Person to Issuer
     (Check all applicable)

     [X]  Director                             [_]  10% Owner
     [_]  Officer (give title below)           [_]  Other (specify below)
________________________________________________________________________________
6.   If Amendment, Date of Original (Month/Day/Year)

________________________________________________________________________________
7.   Individual or Joint/Group Filing  (Check applicable line)

     [X]  Form Filed by One Reporting Person

     [_]  Form Filed by More than One Reporting Person
<TABLE>
<CAPTION>
=============================================================================================================================
                                    Table I -- Non-Derivative Securities Beneficially Owned
=============================================================================================================================
                                                          3. Ownership Form:
                               2. Amount of Securities       Direct (D) or
1. Title of Security              Beneficially Owned         Indirect (I)       4. Nature of Indirect Beneficial Ownership
   (Instr. 4)                     (Instr. 4)                 (Instr. 5)            (Instr. 4)
- -----------------------------------------------------------------------------------------------------------------------------
   <S>                            <C>                         <C>                  <C>

- -----------------------------------------------------------------------------------------------------------------------------

- -----------------------------------------------------------------------------------------------------------------------------

=============================================================================================================================
</TABLE>
Reminder: Report on a separate line for each class of securities beneficially
          owned directly or indirectly.

                            (Print of Type Responses)
                                                                          (Over)
<PAGE>
FORM 3 (continued)
<TABLE>
<CAPTION>
================================================================================================================================
                                    Table II -- Derivative Securities Beneficially Owned
                               (e.g., puts, calls, warrants, options, convertible securities)
================================================================================================================================
                                                                                                   5. Owner-
                                                 3. Title and Amount of Securities                    ship
                                                    Underlying Derivative Security                    Form of
                         2. Date Exercisable        (Instr. 4)                                        Derivative
                            and Expiration Date  ---------------------------------  4. Conver-        Security:
                            (Month/Day/Year)                            Amount         sion or        Direct      6. Nature of
                         ----------------------                         or             Exercise       (D) or         Indirect
                         Date       Expira-                             Number         Price of       Indirect       Beneficial
1. Title of Derivative   Exer-      tion                                of             Derivative     (I)            Ownership
   Security (Instr. 4)   cisable    Date         Title                  Shares         Security       (Instr. 5)     (Instr. 5)
- -------------------------------------------------------------------------------------------------------------------------------
<S>                       <C>        <C>       <C>                     <C>           <C>              <C>            <C>
Series F Preferred Stock,
par value $.01 per share  Immed.     N/A       Common Stock            2,500,000     $0.10            I(1)
- -------------------------------------------------------------------------------------------------------------------------------
Common Stock Purchase
Warrants                  Immed.    3/1/07     Common Stock              250,000     $1.00            I(1)
- -------------------------------------------------------------------------------------------------------------------------------

- -------------------------------------------------------------------------------------------------------------------------------

- -------------------------------------------------------------------------------------------------------------------------------

- -------------------------------------------------------------------------------------------------------------------------------

- -------------------------------------------------------------------------------------------------------------------------------

===============================================================================================================================
</TABLE>
Explanation of Responses:
(1) The reported shares are owned of record by a limited partnership in which
Dr. Hausman is a limited partner. The number of shares reported represents a
best estimate of Dr. Hausman's percentage interest in the limited partnership,
multiplied by the total number of shares held by the limited partnership. In
that Dr. Hausman does not control the general partner of the limited
partnership, and has no investment control over the securities held by the
limited partnership, Dr. Hausman disclaims ownership of the reported shares.


          /s/ Dr. Marvin S. Hausman                              3/22/2002
- ---------------------------------------------            -----------------------
              Dr. Marvin S. Hausman                                Date

**   Intentional misstatements or omissions of facts constitute Federal Criminal
     Violations.

     See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note:  File three copies of this form, one of which must be manually signed.
       If space provided is insufficient, see Instruction 6 for procedure.

                            (Print of Type Responses)
                                                                          Page 2

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
